Australia's Monash IVF rises; Jefferies calls company an attractive asset

Monash IVF

14/01/2026 24:27

Updates

** Shares of Australia's Monash IVF MVF.AX rise as much as 2% to A$0.760, logging their biggest intraday pct gain since January 2

** Jefferies views MVF as an attractive asset, despite consortium withdrawing A$311.7 million ($208.25 million) takeover offer in 2025

** "Would not be surprised to see further potential corporate actions over time," says Jefferies

** Brokerage keeps its forecasts unchanged

** Rates stock "buy", hikes PT to A$0.95 from A$0.80 per share

** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector

** Three of six analysts rate the stock "buy" or higher, three "hold"; their median PT is A$0.84, according to LSEG-compiled data

** Stock lost over 40% in 2025

($1 = 1.4968 Australian dollars)

(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com))